UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Aggressive surgery could overcome the extent of initial peritoneal dissemination for advanced ovarian, fallopian tube, and peritoneal carcinoma

Scientific reports, 2020-12, Vol.10 (1), p.21307-21307, Article 21307

2020

Volltextzugriff (PDF)

Early diagnosis and risk factors for lymphedema following lymph node dissection for gynecologic cancer

Plastic and reconstructive surgery (1963), 2013-02, Vol.131 (2), p.283-290

2013

Volltextzugriff (PDF)

Pretreatment Nutritional Status in Combination with Inflammation Affects Chemotherapy Interruption in Women with Ovarian, Fallopian Tube, and Peritoneal Cancer

Nutrients, 2022-12, Vol.14 (23), p.5183

2022

Volltextzugriff (PDF)

Removal of the entire internal iliac vessel system is a feasible surgical procedure for locally advanced ovarian carcinoma adhered firmly to the pelvic sidewall

International journal of clinical oncology, 2019-08, Vol.24 (8), p.941-949

2019

Volltextzugriff (PDF)

Validity of the 2014 FIGO Stage IIIA1 Subclassification for Ovarian, Fallopian Tube, and Peritoneal Cancers

In vivo (Athens), 2022-09, Vol.36 (5), p.2453-2460

2022

Volltextzugriff (PDF)

Well-trained gynecologic oncologists can perform bowel resection and upper abdominal surgery safely

Journal of Gynecologic Oncology, 2020, 31(1), , pp.1-15

2020

Volltextzugriff (PDF)

Aggressive surgery for advanced ovarian cancer decreases the risk of intraperitoneal recurrence

International journal of clinical oncology, 2020-09, Vol.25 (9), p.1726-1735

2020

Volltextzugriff (PDF)

Surgical Techniques and Outcomes of Colorectal Anastomosis after Left Hemicolectomy with Low Anterior Rectal Resection for Advanced Ovarian Cancer

Cancers, 2021-08, Vol.13 (16), p.4248

2021

Volltextzugriff (PDF)

Bevacizumab in First-Line Chemotherapy Improves Progression-Free Survival for Advanced Ovarian Clear Cell Carcinoma

Cancers, 2021-06, Vol.13 (13), p.3177

2021

Volltextzugriff (PDF)

Safety and Efficacy of Weekly Paclitaxel and Cisplatin Chemotherapy for Ovarian Cancer Patients with Hypersensitivity to Carboplatin

Cancers, 2021-02, Vol.13 (4), p.640

2021

Volltextzugriff (PDF)

Predictors of postoperative pancreatic fistula after splenectomy with or without distal pancreatectomy performed as a component of cytoreductive surgery for advanced ovarian cancer

Journal of Gynecologic Oncology, 2022, 33(3), , pp.1-14

2022

Volltextzugriff (PDF)

Serum FSH as a Useful Marker for the Differential Diagnosis of Ovarian Granulosa Cell Tumors

Cancers, 2022-09, Vol.14 (18), p.4480

2022

Volltextzugriff (PDF)

Introduction of rectosigmoid colectomy improves survival outcomes in early-stage ovarian cancer patients

International journal of clinical oncology, 2021-05, Vol.26 (5), p.986-994

2021

Volltextzugriff (PDF)

Microscopic diseases remain in initial disseminated sites after neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and primary peritoneal cancer

Journal of Gynecologic Oncology, 2020, 31(3), , pp.1-16

2020

Volltextzugriff (PDF)

Efficacy of palonosetron plus aprepitant in preventing chemoradiotherapy-induced nausea and emesis in patients receiving daily low-dose cisplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a phase II study

Supportive care in cancer, 2016-11, Vol.24 (11), p.4633-4638

2016

Volltextzugriff (PDF)

Assessment of intraoperative tube thoracostomy after diaphragmatic resection as part of debulking surgery for primary advanced-stage Müllerian cancer

Gynecologic oncology, 2013-10, Vol.131 (1), p.32-35

2013

Volltextzugriff (PDF)

Daily Low-Dose Cisplatin-Based Concurrent Chemoradiotherapy for the Treatment of Cervical Cancer in Patients 70 Years or Older

International journal of gynecological cancer, 2015-06, Vol.25 (5), p.891-896

2015

Volltextzugriff (PDF)

Surgical anatomy of the common iliac veins during para-aortic and pelvic lymphadenectomy for gynecologic cancer

Journal of Gynecologic Oncology, 2014, 25(1), , pp.64-69

2014

Volltextzugriff (PDF)

Bevacizumab-based Salvage Chemotherapy Improves Survival Outcomes for Patients With Brain Metastasis from Ovarian Cancer

Anticancer research, 2022-05, Vol.42 (5), p.2637-2644

2022

Volltextzugriff (PDF)

Does aggressive surgery only benefit patients with less advanced ovarian cancer?

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5556-5556

2021

Volltextzugriff (PDF)

Learning curve of high-complexity surgery for advanced ovarian cancer

Gynecologic oncology, 2020-01, Vol.156 (1), p.54-61

2020

Volltextzugriff (PDF)

Association between nutritional status and chemotherapy interruption in outpatients with ovarian cancer

Annals of nutrition and metabolism, 2023-08, Vol.79, p.704

2023

Volltextzugriff (PDF)

THE ROLE OF ULTRASOUND IN THE MULTIMODAL IMAGING DIAGNOSIS OF OVARIAN CANCER

Ultrasound in medicine & biology, 2022, Vol.48, p.S51-S52

2022

Volltextzugriff (PDF)

The safety and efficacy of weekly paclitaxel and cisplatin chemotherapy for patients with ovarian cancer who developed carboplatin hypersensitivity reaction in previous chemotherapy

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.6058-6058

2020

Volltextzugriff (PDF)

Effect of bevacizumab in first-line chemotherapy on progression-free survival in advanced ovarian clear cell carcinoma

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e18086-e18086

2020

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(87)

Publikationsform

Artikel
(92)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Aggressive surgery could overcome the extent of initial peritoneal dissemination for advanced ovarian, fallopian tube, and peritoneal carcinoma

Early diagnosis and risk factors for lymphedema following lymph node dissection for gynecologic cancer

Pretreatment Nutritional Status in Combination with Inflammation Affects Chemotherapy Interruption in Women with Ovarian, Fallopian Tube, and Peritoneal Cancer

Removal of the entire internal iliac vessel system is a feasible surgical procedure for locally advanced ovarian carcinoma adhered firmly to the pelvic sidewall

Validity of the 2014 FIGO Stage IIIA1 Subclassification for Ovarian, Fallopian Tube, and Peritoneal Cancers

Well-trained gynecologic oncologists can perform bowel resection and upper abdominal surgery safely

Aggressive surgery for advanced ovarian cancer decreases the risk of intraperitoneal recurrence

Surgical Techniques and Outcomes of Colorectal Anastomosis after Left Hemicolectomy with Low Anterior Rectal Resection for Advanced Ovarian Cancer

Bevacizumab in First-Line Chemotherapy Improves Progression-Free Survival for Advanced Ovarian Clear Cell Carcinoma

Safety and Efficacy of Weekly Paclitaxel and Cisplatin Chemotherapy for Ovarian Cancer Patients with Hypersensitivity to Carboplatin

Predictors of postoperative pancreatic fistula after splenectomy with or without distal pancreatectomy performed as a component of cytoreductive surgery for advanced ovarian cancer

Serum FSH as a Useful Marker for the Differential Diagnosis of Ovarian Granulosa Cell Tumors

Introduction of rectosigmoid colectomy improves survival outcomes in early-stage ovarian cancer patients

Microscopic diseases remain in initial disseminated sites after neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and primary peritoneal cancer

Efficacy of palonosetron plus aprepitant in preventing chemoradiotherapy-induced nausea and emesis in patients receiving daily low-dose cisplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a phase II study

Assessment of intraoperative tube thoracostomy after diaphragmatic resection as part of debulking surgery for primary advanced-stage Müllerian cancer

Daily Low-Dose Cisplatin-Based Concurrent Chemoradiotherapy for the Treatment of Cervical Cancer in Patients 70 Years or Older

Surgical anatomy of the common iliac veins during para-aortic and pelvic lymphadenectomy for gynecologic cancer

Bevacizumab-based Salvage Chemotherapy Improves Survival Outcomes for Patients With Brain Metastasis from Ovarian Cancer

Does aggressive surgery only benefit patients with less advanced ovarian cancer?

Learning curve of high-complexity surgery for advanced ovarian cancer

Association between nutritional status and chemotherapy interruption in outpatients with ovarian cancer

THE ROLE OF ULTRASOUND IN THE MULTIMODAL IMAGING DIAGNOSIS OF OVARIAN CANCER

The safety and efficacy of weekly paclitaxel and cisplatin chemotherapy for patients with ovarian cancer who developed carboplatin hypersensitivity reaction in previous chemotherapy

Effect of bevacizumab in first-line chemotherapy on progression-free survival in advanced ovarian clear cell carcinoma

Suchergebnisse filtern